Vertex Pharmaceuticals Inc. (VRTX)

Index:

Nasdaq 100

$ 388.55
   
  • Change Today:
    $-7.93
  • 52 Week High: $516.74
  • 52 Week Low: $374.46
  • Currency: US Dollars
  • Shares Issued: 256.94m
  • Volume: 1,512,767
  • Market Cap: $99,834m
  • RiskGrade: 164
  • Beta: 0.00

VRTX Overview

Vertex Pharmaceuticals Incorportated in a United States-based drug manufacturer. The company focuses on the research and development of small molecule drugs that are used in the treatment of diseases, including HIV infection & chronic hepatitis C virus.

Listings

Index: S&P 500, Nasdaq 100, Nasdaq Composite
ISIN: US92532F1003

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

VRTX Market Data

Currency US Dollars
Share Price $ 388.55
Change Today $ -7.93
% Change -2.00 %
52 Week High $516.74
52 Week Low $374.46
Volume 1,512,767
Shares Issued 256.94m
Market Cap $99,834m
Beta 0.00
RiskGrade 164

What The Brokers Say

Strong Buy 7
Buy 11
Neutral 10
Sell 1
Strong Sell 1
Total 30
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 10-Sep-2025

Time Volume / Share Price
15:59 100 @ $388.42
15:59 100 @ $388.42
15:59 100 @ $388.42
15:59 100 @ $388.42
15:59 100 @ $388.42

Top of Page